·
3 MIN READ

May 31, 2019: Advocacy spotlight on AMA Opioid Task Force recommendations offer roadmap to policymakers

AMA Opioid Task Force recommendations offer roadmap to policymakers. Learn more about AMA's fight in the opioid epidemic.

Advocacy Update
·
7 MIN READ

May 31, 2019: National Advocacy Update

Surprise billing proposals in Congress, Part D and Medicare Advantage drug pricing and more in the latest AMA national health care advocacy news.

Advocacy Update
·
4 MIN READ

May 31, 2019: State Advocacy Update

A Massachusetts physician seeks to help others and Providers Clinical Support System renewed in the latest state and local advocacy efforts.

Advocacy Update
·
2 MIN READ

May 31, 2019: Judicial Advocacy Update

Learn more about the AMA urging strict enforcement of laws and regulations prohibiting the sale of tobacco products to minors.

Advocacy Update
·
3 MIN READ

AMA Opioid Task Force recommendations offer roadmap to policymakers

The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.

Press Releases
·
8 MIN READ

May 18, 2019: National Advocacy Update

Federal Pain Task Force, prices in drug ads and more in the latest AMA national health care advocacy news.

Advocacy Update
·
4 MIN READ

May 18, 2019: State Advocacy Update

Mississippi and North Carolina's work to end the opioid epidemic, Maine's medication-assisted treatment for inmates and more in AMA's latest state and local advocacy efforts.

Advocacy Update
·
4 MIN READ

6 ways insurers drive the surprise-billing phenomenon

There is bipartisan support in Congress for action on so-called surprise billing—where patients unexpectedly receive a bill for care they thought their insurance covered.

Access to Care
A woman holding a credit card while using a laptop
·
4 MIN READ

AMA to Congress: Patients pay painful price for high drug costs

AMA leader tells of a patient who relies on an older drug that rose in price by 400% to about $80,000 a year. Share your stories to advance drug-pricing transparency.

Public Health